TZP-102

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameTZP-102

Drug Alias NameTZP-102

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists

TargetsGhrelin/growth hormone secretagogue receptor

Therapy Area/IndicationsDiabetic Gastroparesis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesSweden +[9]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTranzyme Inc

Active IndicationsN/A

Inactive IndicationsDiabetic Gastroparesis

ATC CodeN/A